3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
77
Multiple Myeloma
40
Lymphoma, Large B-Cell, Diffuse
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
37
Lymphoma
37
Lymphoma, Non-Hodgkin
27
Leukemia
26
Leukemia, Lymphocytic, Chronic, B-Cell
18
Burkitt Lymphoma
18
Recurrence
17
Lymphoma, Mantle-Cell
17
Lymphoma, Follicular
17
Neoplasms, Plasma Cell
16
Lymphoma, B-Cell
16
Leukemia, Myeloid, Acute
16
Neuroblastoma
12
Hodgkin Disease
12
Lymphoma, Large-Cell, Immunoblastic
11
Myelodysplastic Syndromes
9
Lymphoma, T-Cell, Peripheral
9
Lymphoma, B-Cell, Marginal Zone
9
Inflammatory Breast Neoplasms
9
Triple Negative Breast Neoplasms
8
Sarcoma
8
Ovarian Neoplasms
8
Immunoblastic Lymphadenopathy
7
Neoplasm Metastasis
6
Melanoma
6
Leukemia, Myeloid, Chronic-Phase
6
Hematologic Neoplasms
6
Interventions
Amplified Fragment Length Polymorphism Analysis
2
entrectinib
1
Vinorelbine
1
Trastuzumab
1
Radiomics
1
Pharmacogenomic Testing
1
Neoadjuvant Therapy
1
Molecular Diagnostic Techniques
1
Letrozole
1
Goserelin
1
Gene Expression Profiling
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Lobular
×
Cyclophosphamide
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled